Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 2 | GOYAL PHARMACEUTICALS | Awarded | 1 | ₹55,680 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
27 Jan 2024, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Etophylline BP 84.7 Mg And Theophylline IP 25.3 Mg Per Ml
2 Ml Inj ( 56 vials )
Ipratropium Bromide Respirator Soin 500mcg/2 Ml Respule ( 11600 vials )
5798922
GEM/2023/B/4394619
Two Packet Bid
etophylline BP 84.7 mg and theophylline IP 25.3 mg per ml, 2 ml inj,ipratropium bromide respirator
15 days
Delhi; New Delhi
Item wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
₹31
40%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Etophylline BP 84.7 Mg And Theophylline IP 25.3 Mg Per Ml, 2 Ml Inj ( 56 vials ) | NEW DELHI | 56 | 15 days | - |
| Ipratropium Bromide Respirator Soin 500mcg/2 Ml Respule ( 11600 vials ) | NEW DELHI | 11,600 | 15 days |
Exempted
27 Jan 2024
26 Dec 2023
27 Jan 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5798922.pdf
GEM_BID
re40_2023-12-26-12-36-38_5e0a744e5b783b1a8aa49d0f560be269.pdf
SPECIFICATION
re40_2023-12-26-12-37-51_047b143da89baff3a6b203731205a796.pdf
SPECIFICATION
CFARE40_849bc534-42f9-4a39-8d441703576280484_soharabmudgil.500a@gov.in.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .